ClinicalTrials.Veeva

Menu

Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine

F

Frederikssunds Hospital, Denmark

Status and phase

Completed
Phase 4

Conditions

Spinal Anesthesia

Treatments

Drug: bupivacaine
Drug: Lidocaine

Study type

Interventional

Funder types

Other

Identifiers

NCT01245868
FRS-AN2009-03-09

Details and patient eligibility

About

The purpose of the study is to investigate if a small amount of lignocaine added to bupivacaine for spinal anesthesia to patients planned for arthroscopic knee surgery, can shorten the duration of the sensoric and the motoric blockade.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient want spinal anaesthesia
  • No contradictions against spinal anaesthesia
  • Healthy people (ASA-score 1 or 2)
  • Body mass index < 35 and between 155 and 190 cm

Exclusion criteria

  • Known allergic reactions to planned drugs
  • Neurologic disturbances
  • Diabetes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups, including a placebo group

Bupivacaine
Experimental group
Description:
Bupivacaine as used routinely
Treatment:
Drug: bupivacaine
Lidocaine added to bupivacaine
Placebo Comparator group
Description:
lidocaine is added to bupivacaine
Treatment:
Drug: Lidocaine
Drug: bupivacaine

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems